Canada's Access to Medicines Regime
Use of Patents for International Humanitarian Purposes to Address Public Health Problems
Canada's Access to Medicines Regime (CAMR) authorizes the export of patented medicines in order to make it easier to provide pharmaceutical products to developing nations facing public health crises such as HIV/AIDS, malaria and tuberculosis.
Under sections 21.01 to 21.2 of the Patent Act, the Commissioner of Patents receives applications and has the authority to grant authorization to allow a manufacturer to use a patented invention in order to make and export a drug or device.
- Obtaining and renewing an authorization
- Applications for authorizations and renewals received by CIPO
Find out more about Canada's Access to Medicines Regime.
- Date modified: